We are pleased to share that on 17th February 2026, during the BioAsia 2026 Summit in Hyderabad, an MoU was formally exchanged between the Sri Sathya Sai Biobank & Research Hub (SSSIHL) and WT FABA Biocatalyst LLP (Whale Tank).
This collaboration establishes a structured, reciprocal framework enabling:
- Access to the Sri Sathya Sai Biobank for Whale Tank-supported startups for research, preclinical studies, and innovation
- Access for Sri Sathya Sai Institute of Higher Learning (SSSIHL)and Sri Sathya Sai Research and Innovation Foundation (SSSRIF) to Whale Tank’s GMP facility in Genome Valley
- A defined, transparent payment-based model for shared services
Strong governance around ethics, de-identified clinical data, confidentiality, and IP - As outlined in the MoU, the Sri Sathya Sai Biobank is being established as a state-of-the-art facility dedicated to the collection, preservation, and responsible provision of clinical samples with associated de-identified clinical histories. The initiative also envisions a National Consortium with pan-India reachto support research and innovation across the country.
This partnership reflects SSSIHL’s commitment to:
- Building high-quality biobanking infrastructure
- Supporting biotech startups with clinically relevant resources
- Enabling translational research through industry collaboration
- Integrating academic rigor with GMP-scale biomanufacturing access
We sincerely thank Markandeya Gorantla, Uday Saxena, and the Whale Tank team for their wholehearted support in shaping this collaborative framework.
Through structured partnerships such as this, SSSIHL continues to strengthen India’s ecosystem for responsible biomedical innovation.
